Files

Chaccour_C_Am_J_Trop_Med_Hyg_2020.pdf (65.18 KB)

Document type

Article

Version

Published version

Publication date

2020-04-16

Publication license

cc-by (c) The American Society of Tropical Medicine and Hygiene, 2020
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/160977

Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency.

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.4269/ajtmh.20-0271

Abstract

Ivermectin is a widely used drug for the treatment and control of several neglected tropical diseases.The drug has an excellent safety profile, with more than 2.5 billion doses distributed in the last 30 years, and its potential to reduce malaria transmission by killing mosquitoes is under evaluation in several trials around the world. Ivermectin inhibits the in vitro replication of some positive, single-stranded RNA viruses, namely, dengue virus (DNV), Zika virus, yellow fever virus, and others.

Subject

COVID-19, Salut pública, Administració de medicaments

Subject (English)

COVID-19, Public health, Administration of drugs

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

CHACCOUR, Carlos, et al. Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency. American Journal Of Tropical Medicine And Hygiene . 2020. ISSN 0002-9637. [consulted: 15 of June of 2026]. Available at: https://hdl.handle.net/2445/160977

Export metadata

JSON - METS

Share record